港股异动 | 药明生物(02269)涨超7%领涨CRO概念机构预计CXO行业高景气度持续板块仍具投资价值

智通财经2023-05-22

智通财经APP获悉，CRO概念股早盘普涨，截至发稿，药明生物(02269)涨6.76%，报45港元；康龙化成(03759)涨4.82%，报32.6港元；昭衍新药(06127)涨3.22%，报30.45港元；药明康德(02359)涨2.55%，报70.3港元；凯莱英(06821)涨1.06%，报105.1港元。华安证券此前研报指出，通过对国内外研发热度相关指标（资金面和管线层面）的跟踪，该行认为目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2337163690?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-05-22 10:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2337163690","market":"hk","top_or_hot":-1,"title":"港股异动 | 药明生物(02269)涨超7%领涨CRO概念 机构预计CXO行业高景气度持续 板块仍具投资价值","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股早盘普涨，截至发稿，药明生物(02269)涨6.76%，报45港元；康龙化成(03759)涨4.82%，报32.6港元；昭衍新药(06127)涨3.22%，报30.45港元；药明康德(02359)涨2.55%，报70.3港元；凯莱英(06821)涨1.06%，报105.1港元。华安证券此前研报指出，通过对国内外研发热度相关指标（资金面和管线层面）的跟踪，该行认为目前...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/933565.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 药明生物(02269)涨超7%领涨CRO概念 机构预计CXO行业高景气度持续 板块仍具投资价值</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 药明生物(02269)涨超7%领涨CRO概念 机构预计CXO行业高景气度持续 板块仍具投资价值\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-05-22 10:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/933565.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股早盘普涨，截至发稿，药明生物(02269)涨6.76%，报45港元；康龙化成(03759)涨4.82%，报32.6港元；昭衍新药(06127)涨3.22%，报30.45港元；药明康德(02359)涨2.55%，报70.3港元；凯莱英(06821)涨1.06%，报105.1港元。华安证券此前研报指出，通过对国内外研发热度相关指标（资金面和管线层面）的跟踪，该行认为目前...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/933565.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/933565.html","article_id":"2337163690","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2337163690","pubTimestamp":1684723205,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，CRO概念股早盘普涨，截至发稿，药明生物(02269)涨6.76%，报45港元；康龙化成(03759)涨4.82%，报32.6港元；昭衍新药(06127)涨3.22%，报30.45","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06821":"凯莱英","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","03759":"康龙化成","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU1720050803.USD":"安联全方位中国股票基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1589":"北水核心资产","06127":"昭衍新药","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","02269":"药明生物","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU0823426308.USD":"法巴中国股票基金","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","BK1583":"高瓴概念","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","02359":"药明康德","LU0823426480.USD":"法巴中国股票经典Dis","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0359201612.USD":"贝莱德中国基金A2","BK1521":"挪威政府全球养老基金持仓","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","BK1191":"制药","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","CXO":"康休","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC"},"translate_title":"Hong Kong stocks changed Yaoming Bio (02269) rose more than 7% to lead the CRO concept. The institution expects the CXO industry to continue to have high prosperity and still have investment value","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1,"CXO":1,"02359":0.9,"03759":0.9,"06127":0.9,"06821":0.9},"content_text":"智通财经APP获悉，CRO概念股早盘普涨，截至发稿，药明生物(02269)涨6.76%，报45港元；康龙化成(03759)涨4.82%，报32.6港元；昭衍新药(06127)涨3.22%，报30.45港元；药明康德(02359)涨2.55%，报70.3港元；凯莱英(06821)涨1.06%，报105.1港元。华安证券此前研报指出，通过对国内外研发热度相关指标（资金面和管线层面）的跟踪，该行认为目前全球和国内的新药研发仍然继续保持活跃，由于全球产业链逐渐向国内转移，叠加国内需求快速增长，预计CXO行业高景气度仍将持续，并认为CXO企业短中期业绩高增长具备很强的确定性。该行表示，一方面，CXO头部企业持续承接全球订单，开拓海外市场，营收保持快速增长趋势，市场估值逐渐进入合理区间；另一方面，具有比较优势和自身特色的高成长性公司将会逐渐深度融入全球新药研发体系，迎来自身发展的宝贵机遇期，预计经营业绩会在未来持续呈现高速增长的趋势，具有投资价值。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2337163690"}

港股异动 | 药明生物(02269)涨超7%领涨CRO概念 机构预计CXO行业高景气度持续 板块仍具投资价值

精彩评论

港股异动 | 药明生物(02269)涨超7%领涨CRO概念机构预计CXO行业高景气度持续板块仍具投资价值